Icosapent ethyl drug reduces risk of recurrent cardiovascular events
At a Late Breaking Clinical Trial at the American College of Cardiology's 68th Annual Scientific Session, Deepak L. Bhatt, MD, MPH, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital ...
Mar 18, 2019
0
1